Vimarsana
Biggest News Aggregation in the World

Stan Lapidus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stan Lapidus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stan Lapidus Today - Breaking & Trending Today

Biomed 2024 Showcases Israel's Resilient Entrepreneurial Spirit - Vimarsana News

Biomed 2024 Showcases Israel's Resilient Entrepreneurial Spirit

The 22nd Biomed Israel Conference brings together Israeli Biotech startups, senior pharma and healthcare executives, and global investors.

Source: forbes.com
CellMax Life Announces Expansion of Company Board With Leading Industry Experts - Vimarsana News

CellMax Life Announces Expansion of Company Board With Leading Industry Experts

SUNNYVALE, Calif. April 6, 2023 (PRWEB) April 06, 2023 -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood

Source: prweb.com
World-leading Breast Cancer Oncologists Cynthia Ma MD, PhD and Massimo Cristofanilli, MD to Join Olaris Scientific and Medical Advisory Board - Vimarsana News

World-leading Breast Cancer Oncologists Cynthia Ma MD, PhD and Massimo Cristofanilli, MD to Join Olaris Scientific and Medical Advisory Board

World-leading Breast Cancer Oncologists Cynthia Ma MD, PhD and Massimo Cristofanilli, MD to Join Olaris Scientific and Medical Advisory Board Share Article Drs. Cynthia Ma and Massimo Cristofanilli to Advise on Biomarkers of Response (BoRs) to Drive Better Treatment Outcomes for Patients with Breast Cancer I am impressed by Olaris’s technology and early data suggesting the potential use of a metabolomics signature as an independent and robust predictive biomarker in metastatic breast cancer. - Dr. Cristofanilli WALTHAM, Mass. (PRWEB) ...

Source: prweb.com
BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments - Vimarsana News

BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments

Press release content from Business Wire. The AP news staff was not involved in its creation. BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments February 10, 2021 GMT BigHat co-founders Mark DePristo and Peyton Greenside (Photo: Business Wire) SAN CARLOS, Calif.--(BUSINESS WIRE)--Feb 10, 2021-- BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, today announced it has raised $19 million in an oversubscribed Series A funding round, led by Andreesse...

Source: apnews.com